Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 28;30(44):4725–4737. doi: 10.3748/wjg.v30.i44.4725

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

PMC Copyright notice

During follow-up after the cessation of peginterferon alpha treatment. A: The hepatitis B surface antigen recurrence rate in the hepatitis B surface antibody (HBsAb) < 35.3 mIU/mL and HBsAb ≥ 35.3 mIU/mL groups at the cessation of peginterferon alpha (peg-IFN-α) treatment. ^bP < 0.01; B: The dynamics of median alanine aminotransferase and aspartate transaminase levels during follow-up after the cessation of peg-IFN-α treatment. HBsAb: Hepatitis B surface antibody; HBsAg: Hepatitis B surface antigen; ALT: Alanine aminotransferase; AST: Aspartate transaminase.